Presentation is loading. Please wait.

Presentation is loading. Please wait.

U.S. Therapeutic Apheresis Markets Uptake of Photopheresis in New Indications to Drive Future Revenue Growth “The growing demand for photopheresis in off-label.

Similar presentations


Presentation on theme: "U.S. Therapeutic Apheresis Markets Uptake of Photopheresis in New Indications to Drive Future Revenue Growth “The growing demand for photopheresis in off-label."— Presentation transcript:

1 U.S. Therapeutic Apheresis Markets Uptake of Photopheresis in New Indications to Drive Future Revenue Growth “The growing demand for photopheresis in off-label indications will ignite the therapeutic apheresis market, which has been in a slump in recent years.” Pharmaceutical Biotech Analyst Team Frost & Sullivan

2 High growth in the Photopheresis Market, while the remainder of the Therapeutic Apheresis Market reports flat growth Trend towards segregating blood banking and Therapeutic Apheresis businesses Crossover by dialysis companies into Therapeutic Apheresis Industry Trends

3 Frost & Sullivan provides: Detailed insights into recent developments and trends Drivers, restraints, challenges, and strategic recommendations Analyst insights on ‘hot topics’ and emerging applications in the U.S. Therapeutic Apheresis Markets Market sizing and competitive analysis Market forecasts and market share analysis Pricing analysis Product, vendor and end user analysis Key Features

4 Coverage: The United States Proven methodology encompassing extensive primary and secondary data and research Focused information and strategies that cover business and technology issues Credible data and analysis highlighting industry dynamics Winning strategies to help you create precise business plans What We Offer

5 Current Market Participants Find out how you compare to the competition Assess current and future drivers and restraints Determine and exploit new market share opportunities New Entrants Analyze challenges associated with the industry Calculate time scales for strategy implementation Position yourself to capitalize on the market’s unmet needs Investment Community Analyze long-term strategies of therapeutic apheresis companies Determine which participants will outperform the competition Assess attractiveness of investing in the therapeutic apheresis market Who Will Benefit?

6 Existing and future markets for standard plasmapheresis, plateletpheresis, red cell exchange, leukapheresis, lipidpheresis, extracorporeal immunoadsorption and photopheresis in: Neurology Disorders Hematology and Oncology Disorders Rheumatology Disorders Other Disorders What’s Included

7 Aethlon Medical, Inc. American Association of Blood Banks American Red Cross-Biomedical Services American Society For Apheresis America's Blood Centers B Braun Medical, Inc. Baxter Fenwal/ Baxter Healthcare Corp. BRT Laboratories Carter Bloodcare Celmed Biosciences Circe Biomedical, Inc. Cleveland Clinic-Department of Hematology and Medical Oncology Community Blood Services Of Illinois Florida Blood Services Fresenius Hemocare/ Fresenius AG Gambro BCT, Inc. Good Samaritan Regional Medical Center Haemonetics Corp. Hemacare Corp. Kaneka Pharma America Corp. Kansas City Community Blood Center National Blood Data Resource Center Oklahoma Blood Institute Scott & White Blood Center The Blood Center-Milwaukee Therakos, Inc. Theratechnologies, Inc. (Celmed Biosciences) Tufts-New England Medical Center - Division of Hematology/Oncology Tulane University School of Medicine- Department of Dermatology United Blood Services University Of Southern California- Photopheresis Unit Washington University School of Medicine Key Market Participants

8 Call toll free 877 G O F ROST (877.463.7876) Fax toll free 888.690.3329 E-mail myfrost@frost.com Visit www.frost.com For More Information


Download ppt "U.S. Therapeutic Apheresis Markets Uptake of Photopheresis in New Indications to Drive Future Revenue Growth “The growing demand for photopheresis in off-label."

Similar presentations


Ads by Google